icon-avatar
Global

COMUNICADO: El registro mundial de fibrilación atrial presenta resultados de dos años en 17.000 pacientes con AF (y 3)

    1) Kakkar A.J. (2015, August). Anticoagulation and AF: real life data from the

    GARFIELD-AF registry. Simposio realizado durante el ESC Congress 2015, Londres, Reino

    Unido.

    2) Camm A.J., Ambrosio G., Atar D., et al. Patterns of uptake of non-vitamin K antagonist

    oral anticoagulants in Europe: an analysis from the GARFIELD-AF registry. Sesión

    póster presentada en el ESC Congress 2015, Londres, Reino Unido.

    3) Goto S., Angchaisuksiri P., Camm A.J., et al. Vitamin K antagonist control in Eastern

    and Southeastern Asia. Sesión oral presentada en el ESC Congress 2015, Londres, Reino

    Unido.

    4) Goto S., Atar D., Bassand J.P., et al. Stroke, major bleeding and mortality in newly

    diagnosed atrial fibrillation with moderate-to-severe chronic kidney disease: Results

    from GARFIELD-AF. Sesión póster presentada en el ESC Congress 2015, Londres, Reino

    Unido.

    5) Davis R.C., Hobbs F.D., Kenkre J.E., et al. Prevalence of atrial fibrillation in the

    general population and in high-risk groups: the ECHOES study. Europace 2012; 14(11)

    :1553-9. 6/16/15. Disponible a través de:

    http://europace.oxfordjournals.org/content/14/11/1553.long.

    6) Stefansdottir H., Aspelund T., Gudnason V. et al. Trends in the incidence and

    prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011;

    13(8): 1110-7

    7) Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular Trends in Incidence of Atrial

    Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the

    Projections for Future Prevalence, Circulation. 2006;114,(2)119-125

    8) Zhou Z., Hu D. An epidemiological study on the prevalence of atrial fibrillation in

    the Chinese population of mainland China. J Epidermiol 2008; 18(5):209-16. 6/16/15.

    Disponible a través de:

    https://www.jstage.jst.go.jp/article/jea/18/5/18_JE2008021/_pdf.

    9) Hu D., Sun Y. Epidemiology, risk factors for stroke, and management of atrial

    fibrillation in China. JACC 2008; 52(10):865-8. 6/16/15. Disponible a través de:

    http://www.sciencedirect.com/science/article/pii/S0735109708021141.

    10) Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of Diagnosed Atrial Fibrillation

    in Adults, JAMA. 2001;285,(18)2370-2375

    11) United Nations. World Population Ageing. 2009. Disponible a través de:

    http://www.un.org/esa/population/publications/WPA2009/WPA2009-report.pdf.

    [http://www.un.org/esa/population/publications/WPA2009/WPA2009-report.pdf.%20%20 ]

    Acceso enero de 2015

    12) Kannel W.B., Wolf P.A., Benjamin E.J., et al. Prevalence, incidence, prognosis,

    and predisposing conditions for atrial fibrillation: population-based estimates. Am J

    Cardiol. 1998;82(8A):2N-9N

    13) Atrial Fibrillation Society. The AF Report Atrial Fibrillation: Preventing a

    Stroke Crisis. Disponible a través de

    http://www.preventaf-strokecrisis.org/files/files/The%20AF%20Report%2014%20April%202012.pdf

    . Acceso enero de 2015

    14) European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery,

    Camm A.J , Kirchhof P., Lip G.Y., et al. Guidelines for the management of atrial

    fibrillation: the Task Force for the Management of Atrial Fibrillation of the European

    Society of Cardiology (ESC). 8/22/14. Eur Heart J 2010; 31(19):2369-429. 6/16/15.

    Disponible a través de:

    http://eurheartj.oxfordjournals.org/content/early/2010/09/25/eurheartj.ehq278.full

    .

    15) National Heart, Lung, and Blood Institute. What is Atrial Fibrillation? 6/16/15.

    Disponible a través de:

    http://www.nhlbi.nih.gov/health/dci/Diseases/af/af_what.html.

    16) World Health Organization. The top 10 causes of death. Fact sheet Ngrado(s)310.

    Actualizado mayo de 2014. 6/16/15. Disponible a través de:

    http://www.who.int/mediacentre/factsheets/fs310/en.

    17) International Society on Thrombosis and Haemostasis. About World Thrombosis Day.

    Disponible a través de: http://www.worldthrombosisday.org/about.

    18) American Heart Association. Why Atrial Fibrillation (AF or AFib) Matters. 8/22/14.

    Disponible a través de:

    http://www.heart.org/HEARTORG/Conditions/Arrhythmia/AboutArrhythmia/Why-Atrial-Fibrillation-AF-or-AFib-Matters_UCM_423776_Article.jsp

    .

    19) World Heart Federation. The global burden of stroke. 6/16/15. Disponible a través de:

    http://www.world-heart-federation.org/cardiovascular-health/stroke.

     

    Thrombosis Research Institute London 

    Emmanuel Kaye Building 

    Manresa Road 

    Chelsea 

    Londres SW3 6LR 

     

    Photo:

    http://photos.prnewswire.com/prnh/20150827/261748LOGO

    CONTACTO: Contacto para medios: Gloria Kayani, teléfono:+44(0)207-351-8300 ext. 8390, gkayani@tri-london.ac.uk

    Relacionados

    WhatsAppFacebookFacebookTwitterTwitterLinkedinLinkedinBeloudBeloudBluesky